These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8820408)

  • 1. Correlated motions and propagation of the effect of a local conformational change in the transmembrane helix of the c-erb B2 encoded protein and its V659E mutant, studied by molecular dynamics simulations.
    Garnier N; Genest D; Genest M
    Biophys Chem; 1996 Feb; 58(3):225-37. PubMed ID: 8820408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of a mutation in the transmembrane domain of the p185c-erbB2 oncogene-encoded protein studied by molecular dynamics simulations.
    Garnier N; Genest D; Hebert E; Genest M
    J Biomol Struct Dyn; 1994 Apr; 11(5):983-1002. PubMed ID: 7946067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detailed description of an alpha helix-->pi bulge transition detected by molecular dynamics simulations of the p185c-erbB2 V659G transmembrane domain.
    Duneau JP; Genest D; Genest M
    J Biomol Struct Dyn; 1996 Apr; 13(5):753-69. PubMed ID: 8723771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformation of the transmembrane domain of the c-erbB-2 oncogene-encoded protein in its monomeric and dimeric states.
    Brandt-Rauf PW; Pincus MR; Monaco R
    J Protein Chem; 1995 Jan; 14(1):33-40. PubMed ID: 7779261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib.
    Ou SI; Schrock AB; Bocharov EV; Klempner SJ; Haddad CK; Steinecker G; Johnson M; Gitlitz BJ; Chung J; Campregher PV; Ross JS; Stephens PJ; Miller VA; Suh JH; Ali SM; Velcheti V
    J Thorac Oncol; 2017 Mar; 12(3):446-457. PubMed ID: 27903463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Val(659)-->Glu mutation within the transmembrane domain of ErbB-2: effects measured by (2)H NMR in fluid phospholipid bilayers.
    Sharpe S; Barber KR; Grant CW
    Biochemistry; 2000 May; 39(21):6572-80. PubMed ID: 10828974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into signal transduction: structural alterations in transmembrane helices probed by multi-1 ns molecular dynamics simulations.
    Duneau JP; Garnier N; Genest M
    J Biomol Struct Dyn; 1997 Dec; 15(3):555-72. PubMed ID: 9440002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimer interface of transmembrane domains for neu/erbB-2 receptor dimerization and transforming activation: a model revealed by molecular dynamics simulations.
    Sajot N; Genest M
    J Biomol Struct Dyn; 2001 Aug; 19(1):15-31. PubMed ID: 11565846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane peptides from tyrosine kinase receptor. Mutation-related behavior in a lipid bilayer investigated by molecular dynamics simulations.
    Samna Soumana O; Aller P; Garnier N; Genest M
    J Biomol Struct Dyn; 2005 Aug; 23(1):91-100. PubMed ID: 15918680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics simulations of the transmembrane domain of the oncogenic ErbB2 receptor dimer in a DMPC bilayer.
    Garnier N; Crouzy S; Genest M
    J Biomol Struct Dyn; 2003 Oct; 21(2):179-200. PubMed ID: 12956604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-dependent oligomerization of the Neu transmembrane domain suggests inhibition of "conformational switching" by an oncogenic mutant.
    Beevers AJ; Damianoglou A; Oates J; Rodger A; Dixon AM
    Biochemistry; 2010 Apr; 49(13):2811-20. PubMed ID: 20180588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmembrane domain sequence requirements for activation of the p185c-neu receptor tyrosine kinase.
    Chen LI; Webster MK; Meyer AN; Donoghue DJ
    J Cell Biol; 1997 May; 137(3):619-31. PubMed ID: 9151669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of proto-oncogenic and mutant forms of the transmembrane region of the Neu receptor in TFE.
    Houliston RS; Hodges RS; Sharom FJ; Davis JH
    FEBS Lett; 2003 Jan; 535(1-3):39-43. PubMed ID: 12560075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling of c-erbB2 receptor dimerization: coiled-coil structure of wild and oncogenic transmembrane domains--stabilization by interhelical hydrogen bonds in the oncogenic form.
    Garnier N; Genest D; Duneau JP; Genest M
    Biopolymers; 1997 Aug; 42(2):157-68. PubMed ID: 9234995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of increased length and intact capping sequences to the conformational preference for helix in a 31-residue peptide from the C terminus of myohemerythrin.
    Reymond MT; Huo S; Duggan B; Wright PE; Dyson HJ
    Biochemistry; 1997 Apr; 36(17):5234-44. PubMed ID: 9136885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transmembrane domain of Neu in a lipid bilayer: molecular dynamics simulations.
    van der Ende BM; Sharom FJ; Davis JH
    Eur Biophys J; 2004 Nov; 33(7):596-610. PubMed ID: 15197512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and dynamics of an amphiphilic peptide in a lipid bilayer: a molecular dynamics study.
    Belohorcová K; Davis JH; Woolf TB; Roux B
    Biophys J; 1997 Dec; 73(6):3039-55. PubMed ID: 9414218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the topology of the hydrophobic segment of mammalian diacylglycerol kinase epsilon in a cell membrane and its relationship to predictions from modeling.
    Decaffmeyer M; Shulga YV; Dicu AO; Thomas A; Truant R; Topham MK; Brasseur R; Epand RM
    J Mol Biol; 2008 Nov; 383(4):797-809. PubMed ID: 18801368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane helix packing of ErbB/Neu receptor in membrane environment: a molecular dynamics study.
    Aller P; Garnier N; Genest M
    J Biomol Struct Dyn; 2006 Dec; 24(3):209-28. PubMed ID: 17054379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmembrane helix-helix interactions involved in ErbB receptor signaling.
    Cymer F; Schneider D
    Cell Adh Migr; 2010; 4(2):299-312. PubMed ID: 20212358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.